FindTrial
Sign In

Intranasal oxytocin influences the neural activity to infant faical expressions

Intranasal oxytocin influences the neural activity to infant faical expressions

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018550
Enrollment
Unknown
Registered
2018-09-23
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional perception

Interventions

Oxytocin group :a single dose of 24 UI intranasally self-applied oxytocin
Placebo group:a single dose of 24 UI intranasally self-applied placebo

Sponsors

Faculty of Psychology, Southwest University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 26 Years

Inclusion criteria

Inclusion criteria: 1. Healthy nonparous adults, aged 18-26 years; 2. Participants with informed consent and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Claustrophobia; 2. Have metal in body; 3. history of psychiatric disorder; 4. history of alcohol or other substance abuse or dependence; 5. current usage of any medication; 6. history of rhinitis or current have a cold and nasal congestion; 7. current pregnancy or menstruation.

Design outcomes

Primary

MeasureTime frame
fMRI data;—

Secondary

MeasureTime frame
Score of ECR questionnaire;Score of MDBF questionnaire;—

Countries

China

Contacts

Public ContactChen Xu

Faculty of Psychology, Southwest University

chenxu@swu.edu.cn+86 023-68367642

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026